We are monitoring the impact of COVID-19 on Europe Veterinary Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 63
Share on
Share on

Europe Veterinary/Animal Vaccines Market Research Report - Segmented By Type, Technology and Country (U.K., France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 63
Pages: 138

Europe Veterinary/Animal Vaccines Market Size (2020 to 2025)

As per the report published, the size of the European Veterinary/Animal Vaccines Market is poised to reach USD 2.98 Billion by 2025 from USD 2.34 Billion in 2020, at a CAGR of 4.97% from 2020 to 2025.

Vaccination protects animals from specific infectious diseases and may be carried out either routinely or potentially in an emergency. Immunization of animals used for food can also help protect consumers against zoonotic pathogens such as salmonella.

The European Veterinary/Animal vaccine market is as old as the concept itself, and the newest products are significantly available throughout the market. The farmers and animal husbandry owners seem well versed in the idea of animal vaccination. But the real test lies in the stringent guidelines for animal vaccines testing as per EU regulations. It prevents or at least hardens the route for new players to enter the market. Also, the market has undergone considerable progress during the past few years with the growing usage of continuous cell lines as a substrate and embracing of the fermentor technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics.

Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans, increasing investments by leading players, various government agencies, and animal associations; continuous innovations; raising awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into development of new products.

However, rising maintenance costs for the storage of vaccines, increasing adoption of a vegetarian diet in major economies owing to the increased risk of obesity and other chronic diseases are key restraints of this market.

France Veterinary Vaccines Market

Players in France are manufacturing veterinary vaccines according to the requirements of the European pharmacopeia & OIE norms with specific needs. Vaccine manufacturers are using purified recombinant proteins for vaccination to identify the target. Increasing awareness of zoonotic diseases is a significant contributor to the France veterinary vaccine market. Rising healthcare facilities and infrastructure show a positive impact on the veterinary vaccine and related products in France. The key players of France veterinary vaccine market are Boehringer Ingelheim, Zoetis Inc., and Bayer Healthcare.

Italy Veterinary Vaccines Market

Italy is holding dominant shares of the market following France by owing to the rising number of infectious diseases. Rising awareness about animal health and vaccines will drive the veterinary vaccines market. The Italian veterinary healthcare market developed animal therapeutic products to grow the market. Italy dominated by the export & business investment market. It will open lucrative business opportunities to the key companies to increase their demand in the Italian veterinary vaccines market.

This research report segmented and sub-segmented into the following categories:

  • By Type: Livestock Vaccines (Bovine, Porcine, Ovine, Poultry, Equine) and Companion Vaccines (Caine, Feline)
  • By Technology: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines, and Conjugate Vaccines
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe.

Based on technology, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination.

Regionally, the European region is leading the Global Veterinary/Animal Vaccines Market in terms of consumption.

Prominent companies playing an active role in the Europe Veterinary/Animal Vaccines Market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health. Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health. Inc., Merck & Co. Inc., and Protein Sciences.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                           

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                      

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Type                                                                        

                                5.1.1 Livestock vaccines                                                

                                                5.1.1.1 Bovine                                   

                                                5.1.1.2 Porcine                                 

                                                5.1.1.3 Ovine                                     

                                                5.1.1.4 Poultry                                  

                                                5.1.1.5 Equine                                   

                                5.1.2 Companion vaccines                                                           

                                                5.1.2.1 Canine                                   

                                                5.1.2.2 Feline                                    

                5.2 Technology                                                                 

                                5.2.1 Live attenuated vaccines                                                  

                                5.2.2 Inactivated vaccines                                                            

                                5.2.3 Recombinant vaccines                                                       

                                5.2.4 Toxoid vaccines                                                     

                                5.2.5 Subunit vaccines                                                   

                                5.2.6 DNA vaccines                                                         

                                5.2.7 Conjugate vaccines                                                             

  1. Geographical Analysis

                6.1 Introduction                                                                               

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bayer Healthcare AG                                                                              

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Bioniche Animal Health Canada                                                                         

                8.3 Sanofi Animal Health Inc.                                                                      

                8.4 Biogenesis Bago SA                                                                 

                8.5 Heska Corporation                                                                  

                8.6 Indian Immunologicals Ltd.                                                                  

                8.7 Boehringer Ingelheim GmbH                                                                              

                8.8 Novartis Animal Health, Inc.                                                                

                8.9 Merck & Co. Inc.                                                                       

                8.10 Protein Sciences                                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, Collaborations, and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  2. Europe Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  3. Europe Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  4. Europe Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  5. Europe Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  6. Europe Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  7. Europe Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  8. Europe Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  9. Europe Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  10. Europe Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  11. Europe DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  12. Europe Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  13. Europe Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  14. Europe Bovine Market By Region, From 2020 to 2025 (USD Million)
  15. Europe porcine Market By Region, From 2020 to 2025 (USD Million)
  16. Europe Ovine Market By Region, From 2020 to 2025 (USD Million)
  17. Europe Poultry Market By Region, From 2020 to 2025 (USD Million)
  18. Europe Equine Market By Region, From 2020 to 2025 (USD Million)
  19. Europe Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  20. Europe canine Market By Region, From 2020 to 2025 (USD Million)
  21. Europe feline Market By Region, From 2020 to 2025 (USD Million)
  22. U.K. Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  23. U.K. Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  24. Germany Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  25. Germany Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  26. France Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  27. France Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  28. Italy Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  29. Italy Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  30. Spain Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  31. Spain Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  32. U.K. Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  33. Germany Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  34. France Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  35. Italy Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  36. Spain Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  37. U.K. Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  38. Germany Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  39. France Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  40. Italy Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  41. Spain Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample